Metastatic EGFR-Mutant Lung Adenocarcinoma Patients: A Safety and Efficacy Analysis of First- and Third-Generation EGFR-TKIs December 2, 2025 Middle Eastern Cancer and Oncology Journal, 1(4), 20-25. https://doi.org/10.61706/MECOJ160189